U.S Department of Health & Human ServicesHHSNational Institutes of HealthNIHNCATSNCATSCTSA ProgramCTSA
CTSA CCOS

Coordination, Communication, and Operations Support

RegisterLog In
CTSA News
Need Help

CTSA News

CTSA News

Announcements

Article Details

Publication

georgiactsa.org

Published

January 6, 2026

Share Article

Photo of Dr. Michael Woodworth

Georgia CTSA MSCR Graduate Leads Successful Study for Microbiota Treatments Addressing Antibiotic Resistance

Summary

Georgia CTSA Master of Science in Clinical Research (MSCR) graduate Dr. Michael Woodworth led a pioneering study demonstrating the safety and potential benefits of fecal microbiota transplantation to combat antibiotic-resistant bacteria in long-term care patients. His findings mark a promising advance in addressing “superbug” infections.

Article

Many patients in long-term acute care hospitals (LTACHs) have intestinal multidrug-resistant organism colonization. Despite risk for infection and transmission, no FDA-approved therapies exist to reduce it. To assess the safety and feasibility of fecal microbiota transplantation (FMT), Michael Woodworth, M.D., MSCR, Emory, led a non-randomized trial at a LTACH in Atlanta. Results showed FMT was well tolerated with no related serious adverse events.

Read full article

https://georgiactsa.org/news-events/news/2025/discovery/woodworth-study/index.html

Inaugural UC Systemwide Community Engagement Retreat

Previous

New Research Shows Ambient AI Measurably Improves Healthcare Practitioner Well-being

Next

Coordination, Communication, and Operations Support (CCOS) is funded by theNational Center for Advancing Translational Sciences, National Institutes of Health.

HomeContact UsPrivacy PolicyAccessibility Statement
Freedom of Information (FOIA)Office of Inspector General (OIG)Cookie Preference
X-TwitterLinkedIn icon